Target
Galectin-3
Ligand
BDBM632551
Substrate
n/a
Meas. Tech.
Biological Assay
IC50
19.3±n/a nM
Citation
 BOLLI, MGATFIELD, JGRISOSTOMI, CREMEN, LSAGER, CZUMBRUNN, C GALECTIN-3 INHIBITING 2-HYDROXYCYCLOALKANE-1-CARBAMOYL DERIVATIVES US Patent  US20230348442 Publication Date 11/2/2023 
Target
Name:
Galectin-3
Synonyms:
LEG3_HUMAN | LGALS3 | MAC2
Type:
Enzyme
Mol. Mass.:
26156.54
Organism:
Homo sapiens (Human)
Description:
P17931
Residue:
250
Sequence:
MADNFSLHDALSGSGNPNPQGWPGAWGNQPAGAGGYPGASYPGAYPGQAPPGAYPGQAPPGAYPGAPGAYPGAPAPGVYPGPPSGPGAYPSSGQPSATGAYPATGPYGAPAGPLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI
  
Inhibitor
Name:
BDBM632551
Synonyms:
(2R,3R,4S,5R,6R)-N-(3-chloro-5-cyanophenyl)-4-(4-(3,5-difluoro-4- methylphenyl)-1H-1,2,3-triazol-1-yl)-3,5-dihydroxy-N-((1S,2S)-2- hydroxycyclopentyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-2-carboxamide | US20230348442, Example 1H.4.4
Type:
Small organic molecule
Emp. Form.:
C28H28ClF2N5O6
Mol. Mass.:
604.002
SMILES:
Cc1c(F)cc(cc1F)-c1cn(nn1)[C@H]1[C@@H](O)[C@@H](CO)O[C@H]([C@@H]1O)C(=O)N([C@H]1CCC[C@@H]1O)c1cc(Cl)cc(c1)C#N
Structure:
Search PDB for entries with ligand similarity: